Rock Springs Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Rock Springs Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-148,000	Closed	-$6.83M	–	139
2016 Q3	$6.83M	Buy	148,000 +5,500	+4%	+$310K	0.43%	67
2016 Q2	$7.27M	Buy	142,500 +91,000	+177%	+$4.52M	0.54%	58
2016 Q1	$2.18M	Buy	+51,500	New	+$2.62M	0.18%	110
2014 Q1	–	Sell	-19,800	Closed	-$641K	–	80
2013 Q4	$641K	Buy	+19,800	New	+$587K	0.23%	69

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rock Springs Capital Management's ISEE Position: Q4 2016 in Review

Rock Springs Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 148,000 shares — an estimated $6.83M sold.

Rock Springs Capital Management first reported a position in ISEE in Q4 2013 and held it in 4 quarters. The position peaked at $7.27M in Q2 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

Rock Springs Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Rock Springs Capital Management sold 148,000 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $6.83M.
Rock Springs Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 4 quarters.
Rock Springs Capital Management's IVERIC bio, Inc. Common Stock position peaked at $7.27M in Q2 2016.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Rock Springs Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.